23andMe, a company founded in 2006 to bring genetic testing to the masses, this week lowered the price of its home DNA-testing kit from $299 to $99, co-founder Anne Wojcicki wrote in an official company blog post on December 11.
135731
Home DNA testing company 23andMe lowers prices to $99
116083
Rosetta Genomics completes direct offering;
88480
Mayo Clinic partnership to advance personalized medicine
144683
Ancestry.com sets pricing range
17567
New DNA test may spot risk of autism
9419
Health starts at home
39526
International team finds gene associated with epilepsy
51501
ZymoGenetics offering $79 million in common stock
16407
GSK to acquire human Genome Sciences for US$14.25 per share in cash
160235
DeCODE Genetics purchased by Amgen
175596
Compugen discovers cancer treatment target
16341
Should we regulate people's access to their own genome data?
45572
Down syndrome diagnosed with blood test
34892
Genetic mutations could trigger melanoma
65776
Seniors and people with disabilities may pay steeper price for medical equipment
24400
$9.8 million awarded for stem cell research
40508
The ovarian cancer drug market will more than triple over the next decade, increasing from $460 million in 2011 to $1.4 billion in 2021